Cargando…

Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis

BACKGROUND: Diabetic nephropathy (DN) is a chronic condition resulting from microangiopathy in a high-glucose environment. The evaluation of vascular injury in DN has primarily focused on active molecules of VEGF, namely VEGFA and VEGF2(F2R). Notoginsenoside R1 (NGR1), a traditional anti-inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, ChangYan, Zhong, HuaChen, Ma, JingYuan, Liang, Zhang, Zhang, Le, Liu, Tao, Fan, WenXing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324173/ https://www.ncbi.nlm.nih.gov/pubmed/37415174 http://dx.doi.org/10.1186/s12902-023-01402-6

Ejemplares similares

Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway
por: Huang, Guodong, et al.
Publicado: (2016)

Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity
por: Zhang, Yibing, et al.
Publicado: (2020)

Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway
por: Huang, Guodong, et al.
Publicado: (2017)

Enhancing the inhibition of cell proliferation and induction of apoptosis in H22 hepatoma cells through biotransformation of notoginsenoside R1 by Lactiplantibacillus plantarum S165 into 20(S/R)-notoginsenoside R2
por: Wang, Penghui, et al.
Publicado: (2023)

Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in rats
por: Zou, Shun, et al.
Publicado: (2017)

Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats
por: Luo, Chao, et al.
Publicado: (2019)

Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases
por: Liu, Hai, et al.
Publicado: (2020)

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury
por: Zhu, Ting, et al.
Publicado: (2023)

Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway
por: Tian, Xue, et al.
Publicado: (2022)

Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy
por: Zhou, Ping, et al.
Publicado: (2019)

Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model
por: Jia, Chenglin, et al.
Publicado: (2014)

Protective effects of notoginsenoside R1 on acute lung injury in rats with sepsis
por: Cao, Bo, et al.
Publicado: (2021)

Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway
por: Liu, Xiaoyu, et al.
Publicado: (2021)

Notoginsenoside R1 Facilitated Wound Healing in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Cao, Guangzhao, et al.
Publicado: (2022)

Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review
por: Tong, Qiang, et al.
Publicado: (2019)

Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation
por: Yan, Shijun, et al.
Publicado: (2014)

The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020)

Notoginsenoside R1 Suppresses Inflammatory Signaling and Rescues Renal Ischemia-Reperfusion Injury in Experimental Rats
por: Fan, Chuming, et al.
Publicado: (2020)

Notoginsenoside R(1) prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation via the ERs/PI3K/Akt pathway
por: Li, Guang, et al.
Publicado: (2018)

The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome
por: Wang, Haiyan, et al.
Publicado: (2015)

Notoginsenoside R1 attenuates oxidative stress‐induced osteoblast dysfunction through JNK signalling pathway
por: Li, Xumin, et al.
Publicado: (2021)

Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes
por: ZHONG, LEI, et al.
Publicado: (2015)

Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway
por: Lei, Wei, et al.
Publicado: (2022)

miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
por: Hu, Y, et al.
Publicado: (2016)

Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3
por: Qin, Hai-Long, et al.
Publicado: (2021)

Large‐scale production, purification, and function of a tumor multi‐epitope vaccine: Peptibody with bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020)

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis
por: Liao, Ruyi, et al.
Publicado: (2015)

Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling
por: Zhang, Bin, et al.
Publicado: (2018)

Notoginsenoside R1 Promotes Proliferation and Osteogenic Differentiation of hPDLSCs via Wnt/β-Catenin Signaling Pathway
por: Han, Ruiqi, et al.
Publicado: (2022)

Metabolism Study of Notoginsenoside R(1), Ginsenoside Rg(1) and Ginsenoside Rb(1) of Radix Panax Notoginseng in Zebrafish
por: Wei, Yingjie, et al.
Publicado: (2011)

AP-1 Transcription Factor JunD Confers Protection from Accelerated Nephrotoxic Nephritis and Control Podocyte-Specific Vegfa Expression
por: Cook, H. Terence, et al.
Publicado: (2011)

Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression
por: Zhang, Bin, et al.
Publicado: (2019)

Effects of DJ‑1 on apoptosis and mitophagy of glomerular podocytes
por: Xiao, Jing, et al.
Publicado: (2023)

LINK-A lncRNA activates HIF1α signaling and inhibits podocyte cell apoptosis in diabetic nephropathy
por: Yang, Jing, et al.
Publicado: (2019)

Notoginsenoside R1 induces DNA damage via PHF6 protein to inhibit cervical carcinoma cell proliferation
por: Cai, Ting, et al.
Publicado: (2021)

Effects of Borneol on Pharmacokinetics and Tissue Distribution of Notoginsenoside R1 and Ginsenosides Rg1 and Re in Panax notoginseng in Rabbits
por: Wang, Shixiang, et al.
Publicado: (2013)

Highly Efficient Biotransformation of Notoginsenoside R1 into Ginsenoside Rg1 by Dictyoglomus thermophilum β-xylosidase Xln-DT
por: Li, Qi, et al.
Publicado: (2022)

Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways
por: Yu, Yingli, et al.
Publicado: (2016)

LncRNA TNK2‐AS1 regulated ox‐LDL‐stimulated HASMC proliferation and migration via modulating VEGFA and FGF1 expression by sponging miR‐150‐5p
por: Cai, Tianzhi, et al.
Publicado: (2019)

Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro
por: Xu, Hai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f9um21g0osbdt3lgo6eilqk0ui